A detailed history of Kingswood Wealth Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Kingswood Wealth Advisors, LLC holds 601 shares of UTHR stock, worth $280,306. This represents 0.02% of its overall portfolio holdings.

Number of Shares
601
Previous 739 18.67%
Holding current value
$280,306
Previous $212 Million 18.64%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

SELL
$274.7 - $438.75 $37,908 - $60,547
-138 Reduced 18.67%
601 $252 Million
Q2 2025

Jul 23, 2025

SELL
$276.47 - $328.4 $552 - $656
-2 Reduced 0.27%
739 $212 Million
Q1 2025

Jul 25, 2025

BUY
$304.42 - $380.78 $608 - $761
2 Added 0.27%
741 $228 Million
Q1 2025

Apr 21, 2025

BUY
$304.42 - $380.78 $31,050 - $38,839
102 Added 15.96%
741 $228 Million
Q4 2024

Jan 22, 2025

BUY
$348.66 - $410.0 $222,793 - $261,990
639 New
639 $225 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Kingswood Wealth Advisors, LLC Portfolio

Follow Kingswood Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingswood Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingswood Wealth Advisors, LLC with notifications on news.